vTv Therapeutics (VTVT): Millennium entities disclose 6.9% ownership of Class A shares

Rhea-AI Filing Summary

vTv Therapeutics Inc. is the subject of an amended Schedule 13G filing reporting beneficial ownership of its Class A common stock by several Millennium-affiliated entities and Israel A. Englander. Integrated Core Strategies (US) LLC reports beneficial ownership of 249,027 shares of Class A common stock, representing 6.3% of the class, all with shared voting and dispositive power.

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each report beneficial ownership of 269,874 shares, representing 6.9% of the Class A common stock, with shared voting and dispositive power and no sole voting or dispositive power. The filing explains that securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and related managers, and it states that this structure is not, by itself, an admission of beneficial ownership. A joint filing agreement among the reporting persons is included as an exhibit.

Key Figures

Integrated Core Strategies shares: 249,027 shares Integrated Core Strategies ownership: 6.3% Millennium entities shares: 269,874 shares +3 more

6 metrics

Integrated Core Strategies shares 249,027 shares Beneficially owned Class A common stock; 6.3% of class with shared voting and dispositive power

Integrated Core Strategies ownership 6.3% Percentage of vTv Therapeutics Class A common stock beneficially owned

Millennium entities shares 269,874 shares Beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander

Millennium entities ownership 6.9% Percentage of vTv Therapeutics Class A common stock beneficially owned by each of the Millennium entities and Mr. Englander

Sole voting power 0 shares Each reporting person reports zero shares with sole voting or dispositive power

Shared voting power (Millennium entities) 269,874 shares Shares of Class A common stock over which Millennium entities and Mr. Englander share voting power

Key Terms

beneficial ownership, shared voting power, shared dispositive power, Schedule 13G, +1 more

5 terms

beneficial ownership regulatory

"The securities disclosed herein as potentially beneficially owned by Millennium Management LLC"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

shared voting power regulatory

"Shared Voting Power 269,874.00 7 | Sole Dispositive Power 0.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power regulatory

"Shared Dispositive Power 269,874.00 9 269,874.00"

Schedule 13G regulatory

"single Schedule 13G reporting their beneficial ownership interests"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

joint filing agreement regulatory

"Exhibit I: Joint Filing Agreement, dated as of July 28, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/29/2026 - 06:45 PM Accepted by SEC EDGAR 07/29/2026 - 06:45 PM Learn about SEC filing dates

FAQ

What ownership stake in vTv Therapeutics Inc. (VTVT) does Integrated Core Strategies (US) LLC report?

Integrated Core Strategies (US) LLC reports beneficial ownership of 249,027 shares of vTv Therapeutics Class A common stock, representing 6.3% of the class, with shared voting and shared dispositive power and no sole authority over the shares.

How many vTv Therapeutics (VTVT) shares do Millennium Management LLC and affiliates report owning?

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each report beneficial ownership of 269,874 shares of vTv Therapeutics Class A common stock, representing 6.9% of the class, with shared voting and shared dispositive power and no sole voting or dispositive power.

What voting power do the Millennium entities report over vTv Therapeutics (VTVT) shares?

Each Millennium-affiliated reporting person discloses 0 shares with sole voting power and 269,874 shares with shared voting power. They similarly report no sole dispositive power, only shared dispositive power over the same number of Class A common shares.

Does Israel A. Englander personally report beneficial ownership in vTv Therapeutics (VTVT)?

Yes. Israel A. Englander reports beneficial ownership of 269,874 shares of vTv Therapeutics Class A common stock, or 6.9% of the class, with shared voting and dispositive power. The filing notes the securities are held by entities he helps control but disclaims that this alone admits beneficial ownership.

What is the purpose of the joint filing agreement mentioned for VTVT?

The reporting persons entered a joint filing agreement dated July 28, 2026, allowing Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander to file a single Schedule 13G reporting their beneficial ownership interests in vTv Therapeutics Class A common stock.

Where is vTv Therapeutics Inc. (VTVT) headquartered according to this Schedule 13G/A?

vTv Therapeutics Inc. lists its principal executive offices at 3980 Premier Drive, Suite 110, High Point, North Carolina 27265. This address identifies the company’s main business location for purposes of the ownership disclosure in the Schedule 13G/A filing.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

vTv Therapeutics Inc.

(Name of Issuer)

Class A Common Stock, par value $0.01 per share

(Title of Class of Securities)

918385204

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 918385204

1

Names of Reporting Persons

Integrated Core Strategies (US) LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 249,027.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 249,027.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

249,027.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.3 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 918385204

1

Names of Reporting Persons

Millennium Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 269,874.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 269,874.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

269,874.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 918385204

1

Names of Reporting Persons

Millennium Group Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 269,874.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 269,874.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

269,874.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 918385204

1

Names of Reporting Persons

Israel A. Englander

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 269,874.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 269,874.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

269,874.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: vTv Therapeutics Inc.
(b)	Address of issuer's principal executive offices: 3980 Premier Drive, Suite 110, High Point, North Carolina 27265
Item 2.
(a)	Name of person filing: Integrated Core Strategies (US) LLC Millennium Management LLC Millennium Group Management LLC Israel A. Englander
(b)	Address or principal business office or, if none, residence: Integrated Core Strategies (US) LLC c/o Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
(c)	Citizenship: Integrated Core Strategies (US) LLC - Delaware Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
(d)	Title of class of securities: Class A Common Stock, par value $0.01 per share
(e)	CUSIP No.: 918385204
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page.
(b)	Percent of class: See response to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Integrated Core Strategies (US) LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/28/2026

Millennium Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/28/2026

Millennium Group Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/28/2026

Israel A. Englander

Signature:	/s/ Israel A. Englander
Name/Title:	Israel A. Englander
Date:	07/28/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner

Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of July 28, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.